DD Support Board and Research Team

[DragonBear]

Since the 1980's, how many drugs has HEB

or it's predecessor company gotten approved by the FDA and what is the aggregate amount of money that HEB and its predecessor company has received since the 1980s?

That's not playing fair shajandr! One is not suppose to bring up past failures. Only future dreams for the purpose of "DD". Although I guess my request for a link to any completed Phase III trials isn't very fair either.

Once upon a time I had a good run in Genetech. It's behavior was a little boost in the stock price for Phase I trials being completed successfully. Then another small pop upon successful Phase II. About midway through Phase III the company might update, and a large pop. Of course a successful Phase III completed, and it would really run. This with a biotech which had a very good track record in getting FDA approvals. Other biotechs behave in a like manner. The big kids wait for progressive results.

Fast forward and we have the penny wonder HEB. No track record for getting FDA approvals. The EU grants orphan status for its use against Ebola, and penny investors are suppose to celebrate, throwing puppies and kittens into the air. The PPS predicted to go to da moon, as retail gulps the stock until they Burp. The absence of clinical trials are of no importance in the penny world. Pretend they are not needed or required. Such things get in the way of penny dreams.